Skip to content

Effect of Exercise After Heart Transplantation

Effect of High Intensity Interval-based Aerobic Exercise 1-8 Years After Heart Transplantation. 1 Year Follow Up.

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01091194
Acronym
TEX
Enrollment
51
Registered
2010-03-23
Start date
2009-10-31
Completion date
2011-12-31
Last updated
2013-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Transplantation

Keywords

Heart Transplantation, Aerobic Exercise, Exercise, Physical, Exercise Test, Treadmill Test, VO2 peak, Muscle Strength, Quality of Life, Reinnervation, Heart Rate, Myocardial Function

Brief summary

This is a randomized controlled trial which will include approximately 50 heart transplant recipients 1-8 years after heart transplantation. The intervention and follow up period is 1 year. The primary purpose is to investigate if systematic, high intensity, interval-based aerobic exercise training results in a greater improvement of exercise capacity (measured by VO2peak) than previously shown in heart transplant recipients.

Interventions

OTHERInterval-based aerobic exercise

High intensity interval-based aerobic exercise training. Duration: 1 year. Three 8-weeks supervised periods of physical training 3 times per week. Individual training 2 times per week between these periods.

Sponsors

Helse Sor-Ost
CollaboratorOTHER_GOV
Oslo University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Norwegian heart transplanted patients \> 18 years of age * 1-8 years after heart transplantation * Optimal medical treatment * Stable condition * Written informed consent * Must have access to a physical therapist or personal trainer in their hometown * Motivation for exercise

Exclusion criteria

* Unstable condition * In need of revascularization or other invention * Infections, open wounds or skin diseases * Physical disabilities which prevent participation * Other diseases, illnesses or conditions which contradict exercise

Design outcomes

Primary

MeasureTime frame
Peak oxygen uptake (VO2peak)Before and after the intervention period of 1 year

Secondary

MeasureTime frame
Quality of life measured by questionnairesBefore and after the intervention period of 1 year
Myocardial function measured by echocardiographyBefore and after the intervention period of 1 year
Progression on coronary atherosclerosis measured by intra vascular ultrasound (IVUS)Before and after the intervention period of 1 year
Isokinetic muscle strength of quadriceps and hamstringsBefore and after the intervention period of 1 year
Regular blood screening, lipid profile, inflammatory status, nerve growth factor, biochemical markers for endothelial function, prothrombotic factor, factors connected to vascularization: NT-proBNP and gene expression analysis.Before and after the intervention period of 1 year
Analysis of isolated muscle cells from myocardial biopsyBefore and after the intervention period of 1 year
Reinnervation as judged by autonomic nervous control (Heart Rate Variability)Before and after the intervention period of 1 year
Vascular tone and compliance measured by tonometryBefore and after the intervention period of 1 year

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026